DaVita HealthCare Partners Inc (DVA) : Triple Frond Partners reduced its stake in DaVita HealthCare Partners Inc by 15.0% during the most recent quarter end. The investment management company now holds a total of 850,000 shares of DaVita HealthCare Partners Inc which is valued at $64.1 Million after selling 150,000 shares in DaVita HealthCare Partners Inc , the firm said in a disclosure report filed with the SEC on May 13, 2016.DaVita HealthCare Partners Inc makes up approximately 10.26% of Triple Frond Partners’s portfolio.
Other Hedge Funds, Including , Weik Investment Services Inc reduced its stake in DVA by selling 500 shares or 4.94% in the most recent quarter. The Hedge Fund company now holds 9,625 shares of DVA which is valued at $725,918. DaVita HealthCare Partners Inc makes up approx 0.44% of Weik Investment Services Inc’s portfolio.Park Avenue Institutional Advisers reduced its stake in DVA by selling 29 shares or 2.69% in the most recent quarter. The Hedge Fund company now holds 1,051 shares of DVA which is valued at $79,266. DaVita HealthCare Partners Inc makes up approx 0.07% of Park Avenue Institutional Advisers’s portfolio.Utah Retirement Systems boosted its stake in DVA in the latest quarter, The investment management firm added 100 additional shares and now holds a total of 31,718 shares of DaVita HealthCare Partners Inc which is valued at $2.4 Million. DaVita HealthCare Partners Inc makes up approx 0.07% of Utah Retirement Systems’s portfolio. Allegis Investment Advisors sold out all of its stake in DVA during the most recent quarter. The investment firm sold 572 shares of DVA which is valued $43,140. Tradelink Capital added DVA to its portfolio by purchasing 3,450 company shares during the most recent quarter which is valued at $261,165. DaVita HealthCare Partners Inc makes up approx 0.49% of Tradelink Capital’s portfolio.
DaVita HealthCare Partners Inc closed down -0.2 points or -0.26% at $77.15 with 11,26,200 shares getting traded on Wednesday. Post opening the session at $77.42, the shares hit an intraday low of $76.87 and an intraday high of $77.98 and the price fluctuated in this range throughout the day.Shares ended Wednesday session in Red.
On the company’s financial health, DaVita HealthCare Partners Inc reported $0.92 EPS for the quarter, beating the analyst consensus estimate by $ 0.05 according to the earnings call on May 4, 2016. Analyst had a consensus of $0.87. The company had revenue of $3581.00 million for the quarter, compared to analysts expectations of $3495.91 million. The company’s revenue was up 8.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.86 EPS.
Many Wall Street Analysts have commented on DaVita HealthCare Partners Inc. Shares were Reiterated by RBC Capital Mkts on Feb 16, 2016 to “Sector Perform” and Lowered the Price Target to $ 71 from a previous price target of $80 .
DaVita HealthCare Partners Inc. consists of two divisions Kidney Care and HealthCare Partners (HCP). Kidney Care is a provider of dialysis services in the United States treating patients with chronic kidney failure and end stage renal disease (ESRD). Kidney Care division develops innovative clinical care offers integrated treatment plans personalized care teams and health-management services. As of December 31 2014 we provided dialysis and administrative services in the U.S. through a network of 2179 outpatient dialysis centers in 46 states and the District of Columbia serving a total of approximately 173000 patients. HealthCare Partners division is a patient- and physician-focused integrated health care delivery and management company. HealthCare Partners manages and operates medical groups and affiliated physician networks in Arizona California Nevada Florida and New Mexico. As of December 2014 HealthCare Partners had approximately 837000 members under its care.